Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 7Unknown 4Recruiting 3Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Polycystic Ovary Syndrome 2Diabetes Mellitus, Type 2 2Thyroid Nodule 1Insulin Resistance 1Infertility 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Sitagliptin Phosphate × Clear all
NCT05972928 2023-08-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 2/3 Unknown
80 enrolled

Polycystic Ovary Syndrome

NCT04268563 2021-03-22

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Shahid Beheshti University of Medical Sciences

Phase 1/2 Unknown
80 enrolled

Infertility, Polycystic Ovary Syndrome

NCT04298684 2020-09-11

METNODTHYR

Centre Hospitalier Universitaire de la Guadeloupe

Phase 4 Unknown
90 enrolled
Head & Neck

Diabetes Mellitus, Type 2, Insulin Resistance, Thyroid Nodule

NCT01588587 2012-10-19

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Nagaoka Red Cross Hospital

Unknown
500 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡